This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Study Shows Nurse Involvement With TheONC.org Will Improve Care For Over 365,000 Cancer Patients

NORWALK, Conn., Feb. 13, 2013 /PRNewswire/ -- UBM Medica US today announced that a recent follow-up study shows members of The Oncology Nurse Community ( TheONC.org) continue to apply knowledge from the online network to optimize care for a conservative estimate of over 365,000 cancer patients each year. Oncology nurse members surveyed reported improved understanding of topics such as fertility preservation and cancer pain management, and are continuing to utilize this knowledge in their day-to-day practice. Applying an outcomes-based focus to a unique, structured online community demonstrates how a site such as TheONC can have a real-world impact on clinical practice and patient care. 

Launched in February 2012, TheONC is a free online community exclusively created for oncology nurses and the cancer care teams that support them. With a membership base of over 8,500, TheONC now reaches approximately 20 percent of the oncology nurse universe in the United States. This latest outcomes study was conducted by Improve CME, LLC, a third-party continuing medical education outcomes measurement and analysis company, to assess TheONC as a resource for healthcare providers and to evaluate the impact of an online community on patient care.

"In just one year, we've achieved significant success with TheONC – the size of our membership has grown exponentially, and this latest study continues to confirm that we are meeting a critical need within the oncology nurse community by providing a secure environment where members have access to clinically-relevant information and can share best practices," said Brian Field, EVP, and Managing Director at UBM Medica US.  "These results demonstrate how social platforms can serve as a catalyst for knowledge and behavior change among healthcare providers, with the ultimate goal of improving patient care."

Duplicating the methodology used in the initial 2012 assessment, Improve CME undertook a variety of quantitative and qualitative measurements to measure increases in knowledge, confidence and intent to improve behavior among community members, imposing the same rigors typically applied to formally accredited educational programs to a social platform. At the time of this most recent study, TheONC had over 7,000 members, of which 882 responded. Data collected through the outcomes assessment demonstrated application of information to practice and positive patient impact as follows:

  • 81% of respondents reported that content from TheONC has improved their professional satisfaction
  • 84% of respondents have applied what they've learned on TheONC to day-to-day care of their patients 
  • 89% of outcomes survey respondents reported improving care for a combined total of 12,494 to 19,352 patients with cancer in the month prior to survey completion

"We are pleased to continue working with UBM Medica US on this novel approach to optimizing and measuring the educational benefits of an online community," said Derek Dietze, President of Improve CME, LLC. "Based on our evaluation, we found that site members continue to use what they've learned to improve practice and behavior – ultimately benefitting their patients.  In fact, we conservatively estimate that the 7,156 members of the site at the time of our assessment will improve care for more than 365,000 patients with cancer over the course of a one-year period as a result of their involvement with TheONC."

TheONC.org is supported by an unrestricted grant from Bristol-Myers Squibb.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs